Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • The use and misuse of risk pre...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Export Ready — 
The use and misuse of risk prediction tools for clinical decision-making

The use and misuse of risk prediction tools for clinical decision-making

Bibliographic Details
Main Authors: Marissa C. van Maaren, Tom A. Hueting, Vinzenz Völkel, Marjan van Hezewijk, Luc JA. Strobbe, Sabine Siesling
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Breast
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977623000061
  • Holdings
  • Description
  • Similar Items
  • Staff View
Description
ISSN:1532-3080

Similar Items

  • External validation of 87 clinical prediction models supporting clinical decisions for breast cancer patients
    by: Tom A. Hueting, et al.
    Published: (2023-06-01)
  • Explainable machine learning can outperform Cox regression predictions and provide insights in breast cancer survival
    by: Arturo Moncada-Torres, et al.
    Published: (2021-03-01)
  • Facilitating validation of prediction models: a comparison of manual and semi-automated validation using registry-based data of breast cancer patients in the Netherlands
    by: Cornelia D. van Steenbeek, et al.
    Published: (2019-06-01)
  • The INFLUENCE 3.0 model: Updated predictions of locoregional recurrence and contralateral breast cancer, now also suitable for patients treated with neoadjuvant systemic therapy
    by: M.C. Van Maaren, et al.
    Published: (2025-02-01)
  • The value of time-dependent risk predictions in a screening context - a comprehensive simulation analysis validated on German cancer registry data
    by: Vinzenz Voelkel, et al.
    Published: (2022-09-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs